Company Overview and News

Microsoft 3.0: A Turnaround That Looks Real

2h seekingalpha
The first two versions of Microsoft, those under Bill Gates and then Steve Ballmer as CEO, are history; one with world-beating alpha, one lacking any.

GameStop Can Prosper In The Digital Economy, But Only If It Transforms Itself

3h seekingalpha
GameStop has been left out of video games' massive boom due to its focus on pre-owned games and the industry's increasing digitization and direct-to-consumer nature through mobile and in-game purchases.

Microsoft, Google find fresh flaw in chips, but risk is low - Channel NewsAsia

4h channelnewsasia
Cyber security researchers have found a new security flaw that affects a broad swath of modern computing chips and is related to the Spectre and Meltdown chip flaws that emerged in January.

The lucky 56: Xiaomi IPO to make dozens of workers millionaires

8h scmp
The employees stake in the company may soon be worth US$1 billion to US$3 billion, depending on the stock sale. That works out to $36 million each at the midpoint

Microsoft, Google find fresh flaw in chips, but risk is low

10h reuters
(Reuters) - Cyber security researchers have found a new security flaw that affects a broad swath of modern computing chips and is related to the Spectre and Meltdown chip flaws that emerged in January.

Baidu's AI Drive Hits Speed Bump With COO Departure

10h seekingalpha
The departure of Lu Qi from Baidu could deal a setback to some of the company’s less advanced and more ambitious efforts in artificial intelligence.

Should You Buy HP Enterprise (HPE) Stock Ahead of Earnings?

10h zacks
Shares of Hewlett Packard Enterprise (HPE - Free Report) dipped slightly on Monday, just one day before the company is scheduled to release its latest quarterly earnings report. HPE has lost steam since its strong run to all-time highs earlier this year, but as a key figure in the enterprise tech industry, its earnings announcement has the potential to move the market.

5 Chipmakers Set to Soar as Trump Keeps Trade War on Hold

11h investorplace
U.S. tech companies can finally breathe easy, at least for the time being. U.S. Treasury Secretary Steve Mnuchin on Sunday said that the U.S.-China trade conflict has been put on hold.

Everything Investors Need to Know About Legal Sports Gambling

14h zacks
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research. On this week’s episode, Ben Rains breaks down everything investors need to know about the future of the legal sports gambling industry after the U.S. Supreme Court’s historic ruling.

SNE Stock: Sony Corp (ADR) Is This Decade’s Underappreciated Turnaround | InvestorPlace

16h investorplace
Among the so-called recovery stories, Sony Corp (ADR) (NYSE:SNE) is one of the more intriguing, and frustrating. Last year, SNE stock turned in a massive performance, delivering 60% returns to long-embattled shareholders. This followed a fairly solid 15% haul in 2016.

Blockchain: Party Like It’s 1999? Or 2000?

18h investorplace
I was in the middle of it, Mr. Pinstripe Suit, topped by a nifty fedora. I was also the skunk at the garden party, warning that the end was near, that the boom would bust. When it did bust, and I heard the first stories of ruined young dot-com millionaires, I laughed.

Don’t Bet Against, inc. – It Can Rally 27%

18h investorplace
When a stock has become a big-time winner, many investors bet against it simply because it’s rallied so much. Stocks do get exhausted, but that’s a poor thesis to bet on a stock’s demise — particularly when it comes to a name like, inc. (NYSE:CRM). Salesforce stock has been a beast this year, up 23%. Can it continue?

NetApp (NTAP) Set To Report Q4 Earnings: Is A Beat In Store?

18h zacks
NetApp Inc. (NTAP - Free Report) is scheduled to report fiscal fourth-quarter 2018 results on May 23.

A Spread of ETFs to Mimic Hedge Fund Ideas

18h zacks
After nearly a decade of underperformance, big investors like Bill Ackman, George Soros, Carl Icahn, David Tepper, Larry Robbins, Leon Cooperman, Daniel Loeb, David Einhorn and Stanley Druckenmiller have managed to beat the broad market index this year. The group, often known as hedge funds and one that shifts composition from time to time, gained 0.39% through April as measured by the HFRI Fund Weighted Composite Index against the loss of 0.

Total Returns and Sector Exposure for Growth Indexes

18h marketrealist
Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

16h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

16h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 594918104